SpringerLink
Log in

Care for Patients Dying with a Left Ventricular Assist Device

  • Chapter
  • First Online:
End-of-Life Care in Cardiovascular Disease

Abstract

Left ventricular assist devices (LVADs) are increasingly being used to support patients with advanced heart failure, both as a bridge to heart transplantation and as a final or ‘destination’ therapy. Compared with continued medical therapy alone, these devices prolong survival and improve overall patient functional status and quality of life – as such LVADs are not a strictly palliative therapy. However, life with LVAD support is frequently accompanied by device-related complications such as bleeding, ventricular arrhythmias, infection, stroke, renal failure, and right ventricular failure. Management of the LVAD-supported patient who has experienced device-related complications requires both a focus on the underlying pathophysiology and the patient’s overall goals of care. Palliative or supportive care approaches serve an important complementary role in the management of these patients and may also be used to inform decision-making prior to device implantation. We present a review of the complications of LVAD support and their treatment, describe a role for palliative care in the management of these patients, and consider future directions for research to improve the care of LVAD-supported patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–220.

    Article  PubMed  Google Scholar 

  2. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–44.

    Article  PubMed  Google Scholar 

  3. Ammar KA, Jacobsen SJ, Mahoney DW, et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation. 2007;115(12):1563–70.

    Article  PubMed  Google Scholar 

  4. Adler ED, Goldfinger JZ, Kalman J, Park ME, Meier DE. Palliative care in the treatment of advanced heart failure. Circulation. 2009;120(25):2597–606.

    Article  PubMed  Google Scholar 

  5. Bekelman DB, Havranek EP, Becker DM, et al. Symptoms, depression, and quality of life in patients with heart failure. J Card Fail. 2007;13:643–8.

    Article  PubMed  Google Scholar 

  6. Felker GM, O’Connor CM. Inotropic therapy for heart failure: an evidence-based approach. Am Heart J. 2001;142(3):393–401.

    Article  PubMed  CAS  Google Scholar 

  7. Stevenson LW. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy. Circulation. 2003;108(4):492–7.

    Article  PubMed  Google Scholar 

  8. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147–239.

    Article  PubMed  Google Scholar 

  9. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report–2012. J Heart Lung Transplant. 2012;31(10):1052–64.

    Article  PubMed  Google Scholar 

  10. Feldman D, Pamboukian SV, Teuteberg JJ, et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32(2):157–87.

    Article  PubMed  Google Scholar 

  11. Goldstein NE, May CW, Meier DE. Comprehensive care for mechanical circulatory support: a new frontier for synergy with palliative care. Circ Heart Fail. 2011;4(4):519–27.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Heart Failure Society of America. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16(6):e1–192.

    Article  Google Scholar 

  13. McMurray JJ, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787–847.

    Article  PubMed  Google Scholar 

  14. Rose E, et al. Long-term use of a left ventricular assist device. N Engl J Med. 2001;345(20):1435–43.

    Article  PubMed  CAS  Google Scholar 

  15. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357(9):885–96.

    Article  PubMed  CAS  Google Scholar 

  16. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241–51.

    Article  PubMed  CAS  Google Scholar 

  17. Kirklin JK, Naftel DC, Kormos RL, et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32(2):141–56.

    Article  PubMed  Google Scholar 

  18. Rogers JG, Aaronson KD, Boyle AJ, et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010;55(17):1826–34.

    Article  PubMed  Google Scholar 

  19. Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139(5):1316–24.

    Article  PubMed  Google Scholar 

  20. Topkara VK, Kondareddy S, Malik F, et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg. 2010;90(4):1270–7.

    Article  PubMed  Google Scholar 

  21. Oswald H, Schultz-Wildelau C, Gardiwal A, et al. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail. 2010;12(6):593–9.

    Article  PubMed  Google Scholar 

  22. Santambrogio L, Bianchi T, Fuardo M, et al. Right ventricular failure after left ventricular assist device insertion: preoperative risk factors. Interact Cardiovasc Thorac Surg. 2006;5(4):379–82.

    Article  PubMed  Google Scholar 

  23. Hasin T, Topilsky Y, Kremers WK, et al. Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival. Am J Cardiol. 2012;110(9):1322–8.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Tedford RJ, Hemnes AR, Russell SD, et al. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail. 2008;1(4):213–9.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  25. Rich S, Seidlitz M, Dodin E, et al. The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest. 1998;114(3):787–92.

    Article  PubMed  CAS  Google Scholar 

  26. Kushnir VM, Sharma S, Ewald GA, et al. Evaluation of GI bleeding after implantation of left ventricular assist device. Gastrointest Endosc. 2012;75(5):973–9.

    Article  PubMed  Google Scholar 

  27. Uriel N, Pak S-W, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56(15):1207–13. Cited 12 Jul 2013.

    Article  PubMed  Google Scholar 

  28. Crow S, Chen D, Milano C, et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg. 2010;90(4):1263–9; discussion 1269.

    Article  PubMed  Google Scholar 

  29. Wever-Pinzon O, Selzman CH, Drakos SG, et al. Pulsatility and the risk of non-surgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail. 2013;6(3):517–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23479562. Cited 22 May 2013.

    Article  PubMed  CAS  Google Scholar 

  30. Moazami N, Milano CA, John R, et al. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. Ann Thorac Surg. 2013;95(2):500–5.

    Article  PubMed  Google Scholar 

  31. Al-Quthami AH, Jumean M, Kociol R, et al. Eptifibatide for the treatment of HeartMate II left ventricular assist device thrombosis. Circ Heart Fail. 2012;5(4):e68–70.

    Article  PubMed  CAS  Google Scholar 

  32. Thomas MD, Wood C, Lovett M, Dembo L, O’Driscoll G. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban. J Heart Lung Transplant. 2008;27(8):925–7.

    Article  PubMed  Google Scholar 

  33. Refaat MM, Tanaka T, Kormos RL, et al. Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients. J Card Fail. 2012;18(2):140–5.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Sears SF, Hauf JD, Kirian K, Hazelton G, Conti JB. Posttraumatic stress and the implantable cardioverter-defibrillator patient: what the electrophysiologist needs to know. Circ Arrhythm Electrophysiol. 2011;4(2):242–50.

    Article  PubMed  Google Scholar 

  35. Ambardekar AV, Allen LA, Lindenfeld J, et al. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant. 2010;29(7):771–6.

    Article  PubMed  Google Scholar 

  36. Osaki S, Alberte C, Murray MA, et al. Successful radiofrequency ablation therapy for intractable ventricular tachycardia with a ventricular assist device. J Heart Lung Transplant. 2008;27(3):353–6.

    Article  PubMed  Google Scholar 

  37. Dandamudi G, Ghumman WS, Das MK, Miller JM. Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices. Heart Rhythm. 2007;4(9):1165–9.

    Article  PubMed  Google Scholar 

  38. Hasin T, Topilsky Y, Schirger JA, et al. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol. 2012;59(1):26–36.

    Article  PubMed  Google Scholar 

  39. OPTN Policy 3.7 – Allocation of Thoracic Organs. 2013:1–45. http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy_9.pdf.

  40. Wever-Pinzon O, Drakos SG, Kfoury AG, et al. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation. 2013;127(4):452–62.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Lachman VD. Left ventricular assist device deactivation: ethical issues. Medsurg Nurs. 2011;20(2):98–100.

    PubMed  Google Scholar 

  42. MacIver J, Ross HJ. Withdrawal of ventricular assist device support. J Palliat Care. 2005;21(3):151–6.

    PubMed  Google Scholar 

  43. Mueller PS, Swetz KM, Freeman MR, et al. Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc. 2010;85(9):791–7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division, Department of Internal Medicine, Washington University in St Louis, 660 S. Euclid Ave., 8086, St. Louis, MO, 63110, USA

    Justin M. Vader MD & Susan M. Joseph MD

Authors
  1. Justin M. Vader MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan M. Joseph MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susan M. Joseph MD .

Editor information

Editors and Affiliations

  1. Portland VA Medical Center,, Patient-Centered Education and Research, Salt Lake City, UT, USA, Portland, Oregon, USA

    Sarah J. Goodlin

  2. Washington University School of Medicine, St Louis, Missouri, USA

    Michael W. Rich

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Vader, J.M., Joseph, S.M. (2015). Care for Patients Dying with a Left Ventricular Assist Device. In: Goodlin, S., Rich, M. (eds) End-of-Life Care in Cardiovascular Disease. Springer, London. https://doi.org/10.1007/978-1-4471-6521-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6521-7_13

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6520-0

  • Online ISBN: 978-1-4471-6521-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation